You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PDX

Showing 1 - 25 of 160
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Non-Small Cell Lung Carcinoma Trial in Seoul (Pembrolizumab Injection)

Recruiting
  • Metastatic Non-Small Cell Lung Carcinoma
  • Pembrolizumab Injection
  • Seoul, Korea, Republic of
    Samsung Medical Center
Nov 6, 2022

Reconstitution ofHuman Immune System inPatient Derived Xenograft

Suspended
  • Genito Urinary Cancer
  • +3 more
  • Bone marrow biopsy
  • Tumor biopsy
  • Durham, North Carolina
    Duke University Medical Center
Nov 17, 2022

Triple Negative Breast Cancer Trial in Shanghai (Personalized treatment guided by mini-PDX and RNA sequencing, Nab paclitaxel,

Recruiting
  • Triple Negative Breast Cancer
  • Personalized treatment guided by mini-PDX and RNA sequencing
  • +5 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 18, 2022

Precise Prediction of Therapy Efficiency Trial (biopsy of tumor before treatment)

Not yet recruiting
  • Precise Prediction of Therapy Efficiency
  • biopsy of tumor before treatment
  • (no location specified)
Jan 31, 2023

Development of Patient Derived Xenografts (PDX) in Breast Cancer

Recruiting
  • Breast Cancer
  • Residual
  • chemotherapy or endocrine therapy for breast cancer
  • Rochester, Minnesota
    Mayo Clinic
Feb 3, 2022

PRecision Oncology CUhk pRogrammE (PRO-CURE)

Recruiting
  • Gastrointestinal Cancers
  • NGS, PDO/PDX establishment
  • Hong Kong, Hong Kong
    The Chinese University of Hong Kong
Jul 18, 2022

Type2 Diabetes Trial in Jakarta (Vitamin D 5000 IU, Placebo)

Active, not recruiting
  • Type2 Diabetes Mellitus
  • Vitamin D 5000 IU
  • Placebo
  • Jakarta, DKI Jakarta, Indonesia
    Community Health Centers Kecamatan Mampang Prapatan
Oct 24, 2022

Precision Medicine for Every Child With Cancer

Recruiting
  • Childhood Cancer
  • +5 more
  • Whole Genome Sequencing
  • +6 more
  • Adelaide, Australia
  • +8 more
Jan 24, 2023

Lymphoma Trial in New York (pralatrexate)

Completed
Has Results
  • Lymphoma
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Aug 20, 2021

Pivotal Study for Validation of Philips Dx (PDx)

Completed
Has Results
  • Pathologic Processes
    • Silver Spring, Maryland
    • +3 more
    May 4, 2021

    Soft Tissue Sarcoma, Xenograft Model, 2D/3D Cell Cultures Trial in Amsterdam (tumor biopsy)

    Recruiting
    • Soft Tissue Sarcoma
    • +2 more
    • tumor biopsy
    • Amsterdam, Netherlands
      Netherlands Cancer Institute
    Aug 3, 2021

    Patient-derived Xenograft Modeling of Treatment Response for

    Completed
    • Triple Negative Breast Cancer
    • Chemotherapy
    • New York, New York
      Dubin Breast Center of The Tisch Cancer Institute at Mount Sinai
    Jul 1, 2020

    Anaplastic Large Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype, Recurrent Anaplastic Large Cell Lymphoma

    Recruiting
    • Anaplastic Large Cell Lymphoma
    • +19 more
    • Duarte, California
    • +2 more
    Aug 15, 2022

    Lymphoma, B-Cell Trial in United States (Pralatrexate, Vitamin B12, Folic Acid)

    Completed
    Has Results
    • Lymphoma, B-Cell
    • Beverly Hills, California
    • +10 more
    Oct 7, 2021

    Breast Cancer, Liver Metastases Trial in Leuven

    Not yet recruiting
    • Breast Cancer
    • Liver Metastases
      • Leuven, Belgium
        Sophia Leduc
      Jan 31, 2023

      Breast Cancer Female Trial in Clermont-Ferrand (blood samples collection)

      Recruiting
      • Breast Cancer Female
      • blood samples collection
      • Clermont-Ferrand, Puy-de-Dôme, France
        Centre Jean PERRIN
      Mar 9, 2022

      APDS Trial in Netherlands, United States (Leniolisib)

      Not yet recruiting
      • APDS
      • Los Angeles, California
      • +4 more
      Jan 12, 2023

      Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Best Practice, Ibrutinib, Patient Derived

      Unknown status
      • Recurrent Mantle Cell Lymphoma
      • Refractory Mantle Cell Lymphoma
      • Best Practice
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Mar 23, 2020

      Hepatic Encephalopathy Trial in Toulouse (Polydextrose)

      Not yet recruiting
      • Hepatic Encephalopathy
      • Polydextrose
      • Toulouse, France
        Toulouse University Hospital
      Jan 11, 2022

      Constipation, Gastrointestinal Dysfunction Trial (Polydextrose, -controlled)

      Completed
      • Constipation
      • Gastrointestinal Dysfunction
      • Polydextrose
      • placebo-controlled
      • (no location specified)
      Apr 1, 2022

      PDX Models From EGFR Mutant Tumors

      Withdrawn
      • Non Small Cell Lung Cancer
        • San Carlos, California
          Addario Lung Cancer Medical Institute
        Jan 6, 2020

        Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)

        Not yet recruiting
        • Myeloproliferative Neoplasm
        • Secondary Leukemia
        • Multiomic characterization
        • In vitro drug screening
        • (no location specified)
        Aug 28, 2023

        Hyper-Personalized Medicine Using Patient Derived Xenografts for

        Recruiting
        • Kidney Neoplasm
        • +2 more
          • Toronto, Ontario, Canada
            Odette Cancer Centre
          Mar 24, 2022

          APDS Trial in France, Netherlands, United States (Leniolisib)

          Not yet recruiting
          • APDS
          • Los Angeles, California
          • +3 more
          Jul 8, 2022

          Prospective Primary Human Lungcancer Organoids to Predict

          Recruiting
          • Lung Cancer
          • Organoids
          • Heerlen, Netherlands
          • +1 more
          Feb 22, 2022